Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia
Heikki Kuusanmäki(University of Helsinki), Caroline A. Heckman(University of Helsinki)
Cited by 184
Related Papers
Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia
|Blood|2022|123
JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell–induced protection of AML
|Blood|2017|122
The Tyrosine Kinase Inhibitor Cediranib Blocks Ligand-Induced Vascular Endothelial Growth Factor Receptor-3 Activity and Lymphangiogenesis
|Cancer Research|2008|117